Coagulation and fibrinolytic parameters in patients with pulmonary hypertension (Q42523655)

1 November 2017

title

Coagulation and fibrinolytic parameters in patients with pulmonary hypertension (English)

1 reference

1 November 2017

main subject

arterial hypertension

0 references

5

Favaloro R

1 reference

1 November 2017

Altman R

1

1 reference

1 November 2017

Scazziota A

2

1 reference

1 November 2017

Rouvier J

3

1 reference

1 November 2017

Gurfinkel E

4

1 reference

1 November 2017

Perrone S

6

1 reference

1 November 2017

Fareed J

7

1 reference

1 November 2017

publication date

1 July 1996

1 reference

1 November 2017

1 reference

1 November 2017

volume

19

1 reference

1 November 2017

issue

7

1 reference

1 November 2017

page(s)

549-554

1 reference

Inhaled nitric oxide in congenital heart disease.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

Endothelial dysfunction in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

The effect of citrate on euglobulin methods of estimating fibrinolytic activity

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Platelet activation and fibrinopeptide formation in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190706

7 January 2021

Identifiers

DOI

10.1002/CLC.4960190706

1 reference

1 November 2017

1 reference